Skip to Main content Skip to Navigation
Journal articles

Considering personalized Interferon-β therapy for COVID-19

Abstract : Davoudi-Monfared et al. (1) report in this Journal the results from a clinical trial on COVID-19 patients showing that subcutaneous administration of interferon-β (IFN-β) was associated with a more rapid recovery from SARS-CoV-2 infection and decreased mortality.….
Document type :
Journal articles
Complete list of metadata

https://hal.sorbonne-universite.fr/hal-03138348
Contributor : Gestionnaire Hal-Su <>
Submitted on : Thursday, February 11, 2021 - 10:12:50 AM
Last modification on : Monday, February 15, 2021 - 5:19:14 PM

File

Antimicrobial Agents and Chemo...
Publication funded by an institution

Identifiers

Citation

Karim Dorgham, Avidan Neumann, Maxens Decavele, Charles-Edouard Luyt, Hans Yssel, et al.. Considering personalized Interferon-β therapy for COVID-19. Antimicrobial Agents and Chemotherapy, American Society for Microbiology, 2021, ⟨10.1128/aac.00065-21⟩. ⟨hal-03138348⟩

Share

Metrics

Record views

118

Files downloads

24